Sun Wave Pharma S.R.L.
Sun Wave Pharma S.R.L., a prominent player in the pharmaceutical industry, is headquartered in Romania (RO) and operates extensively across various regions. Founded in 2005, the company has established itself as a leader in the development and distribution of high-quality generic medications and innovative healthcare solutions. With a diverse portfolio that includes therapeutic areas such as cardiology, oncology, and neurology, Sun Wave Pharma is committed to enhancing patient care through its unique formulations and rigorous quality standards. The company has achieved significant milestones, including strategic partnerships and a growing presence in international markets, solidifying its position as a trusted name in pharmaceuticals. Recognised for its dedication to research and development, Sun Wave Pharma continues to push the boundaries of medical science, ensuring that it meets the evolving needs of healthcare professionals and patients alike.
DitchCarbon Score
How does Sun Wave Pharma S.R.L.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sun Wave Pharma S.R.L.'s score of 15 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sun Wave Pharma S.R.L.'s reported carbon emissions
In 2023, Sun Wave Pharma S.R.L. reported total carbon emissions of approximately 41,174,000 kg CO2e for Scope 1 and about 261,803,000 kg CO2e for Scope 2. This reflects a slight decrease in Scope 1 emissions from 47,743,000 kg CO2e in 2022, while Scope 2 emissions increased from 254,394,000 kg CO2e in the previous year. The company has not disclosed any Scope 3 emissions data, nor have they set specific reduction targets or climate pledges. Despite the absence of formal commitments, Sun Wave Pharma's emissions data indicates ongoing monitoring and reporting of their carbon footprint, aligning with industry standards for transparency in climate impact. Overall, while the company has made progress in reducing Scope 1 emissions, the increase in Scope 2 emissions highlights the need for further initiatives to enhance their climate commitments and overall sustainability strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 47,743,000 | 00,000,000 |
| Scope 2 | 254,394,000 | 000,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sun Wave Pharma S.R.L. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
